VENTO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 1.059
EU - Europa 855
AS - Asia 635
SA - Sud America 219
AF - Africa 13
OC - Oceania 1
Totale 2.782
Nazione #
US - Stati Uniti d'America 1.034
SG - Singapore 286
BR - Brasile 188
IE - Irlanda 180
SE - Svezia 173
CN - Cina 139
RU - Federazione Russa 121
IT - Italia 119
DE - Germania 75
HK - Hong Kong 74
PL - Polonia 52
VN - Vietnam 39
IN - India 29
FI - Finlandia 28
FR - Francia 28
GB - Regno Unito 25
JP - Giappone 16
AR - Argentina 11
CA - Canada 11
BE - Belgio 9
LT - Lituania 9
ES - Italia 8
IQ - Iraq 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
BD - Bangladesh 6
TR - Turchia 6
UZ - Uzbekistan 6
EC - Ecuador 5
MX - Messico 5
NL - Olanda 5
PE - Perù 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
UA - Ucraina 4
AZ - Azerbaigian 3
ID - Indonesia 3
IR - Iran 3
PA - Panama 3
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
MA - Marocco 2
PK - Pakistan 2
SA - Arabia Saudita 2
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CO - Colombia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
TW - Taiwan 1
Totale 2.782
Città #
Chandler 205
Ashburn 201
Dublin 178
Singapore 147
Nyköping 120
Dallas 74
Hong Kong 74
Beijing 53
Warsaw 49
Messina 48
Moscow 39
The Dalles 38
Munich 34
Los Angeles 33
Princeton 33
Medford 24
Bremen 23
Des Moines 20
Ho Chi Minh City 16
São Paulo 16
Helsinki 14
Turku 14
Dearborn 13
Ann Arbor 12
Hyderabad 12
Buffalo 11
Jinan 11
Rome 11
Frankfurt am Main 10
Kameido 10
Redondo Beach 10
Brussels 9
Jacksonville 9
Mumbai 9
Hanoi 8
Nanjing 8
Atlanta 7
Boardman 7
New York 7
Seattle 7
Stockholm 7
Tianjin 7
Dong Ket 6
Hangzhou 6
Nuremberg 6
Tokyo 6
West Jordan 6
Bexley 5
Denver 5
Orem 5
Tashkent 5
Blumenau 4
Brooklyn 4
Chicago 4
Curitiba 4
Goiânia 4
Nanchang 4
Ottawa 4
Porto Alegre 4
Quito 4
Redwood City 4
Santa Clara 4
Waverly Hall 4
Amsterdam 3
Baku 3
Campinas 3
Catania 3
Florence 3
Jakarta 3
Johannesburg 3
Lima 3
Manaus 3
Manchester 3
Milan 3
Mislata 3
Oklahoma City 3
Olomouc 3
Pune 3
Salvador 3
San Francisco 3
Santa Domenica 3
São Bernardo do Campo 3
Temple 3
Toronto 3
Torregrotta 3
Vienna 3
Wroclaw 3
Alvorada 2
Ankara 2
Augusta 2
Baghdad 2
Bauru 2
Belo Horizonte 2
Bismarck 2
Carney 2
Chengdu 2
Columbus 2
Council Bluffs 2
Dhaka 2
Dubai 2
Totale 1.834
Nome #
PRRT Retreatments: Renal Function Evaluation 146
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 146
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 134
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 134
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 129
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 124
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 120
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 118
Dual Time-Point FET-PET/CT in Glioma Patients: a Single-Centre Preliminary Experience 116
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 115
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 113
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 113
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 111
PRRT retreatments: renal function evaluation 110
Renal Function Evaluation in PRRT Retreatments 106
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 102
Peptide Receptor Radionuclide Therapy of Pulmonary Neuroendocrine Neoplasms: a Single-Centre Experience 94
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 92
Artifcial intelligence applications in SSTR targeted PET/CT images: prediction of response assessment in GEP-NETs undergoing PRRT with [177Lu]DOTATOC 91
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 87
The utility of dual time-point FET-PET/CT in recurrence assessment of glioma patients 85
Artificial intelligence applications in 68Ga-DOTA PETICT images: Prediction of response assessment in GEP-NETs undergoing PRRT with 177Lu-DOTATOC 77
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 64
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 63
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature 51
Response prediction to PRRT in progressing and metastatic GEP-NET undergoing restaging 68Ga-DOTA PETICT: A preliminary multicenter radiomics study 51
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals 50
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 45
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study 41
null 23
Totale 2.851
Categoria #
all - tutte 12.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 12 12 13 18 11 9 9
2021/2022228 1 13 2 10 20 1 21 21 2 25 20 92
2022/2023626 55 90 27 59 46 58 8 46 217 5 12 3
2023/2024146 13 13 7 8 18 22 9 10 0 13 13 20
2024/2025765 9 22 17 30 50 25 54 118 169 68 122 81
2025/2026842 174 118 102 103 171 174 0 0 0 0 0 0
Totale 2.851